Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > What happened to Troy Media?
View:
Post by Metalsguy1 on Mar 30, 2021 11:12am

What happened to Troy Media?

Has anybody else noticed that every trace of that silly Troy Media announcement has disappeared. Where are all those big nvestors Leede and Cannacord were supposed to bring in. Short report only shows the current short position but it does not reflect all the short and covering in between reports. Looks to me like Leede and Canaccord have finished laundering their shares and are just sitting on their free warrants. Time to move on with the next spike.
Comment by MustangSalley on Mar 30, 2021 4:45pm
incompetent management that's what happened!   Tolekis has no experience with capital markets nor dealing with pharma at a corporate level. No pharma deals in last five years ??? He buys the coating immunotherapy and supposedly owns it but can't even do a in house lab trial ??? Where's his Global Advisory Board ? Investors relation ...don't get me started . He paid $1 million ...more  
Comment by Sailboatdream on Mar 31, 2021 12:35pm
See your point Sally.  There is growing consensus that the science is great but management team out of their depth.  I for one do not see a clear plan / path to $4.  This should be the priority at the next AGM.  If no clear path, one of the big pharmas should take over... they would know what to do with this.   as for the "tree" analogy of the conference call 2 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities